Newsroom

Jan 4, 2024

OnQuality Announces FDA Clearance of IND Application for OQL025 for the treatment of EGFR Inhibitor-Induced Acneiform Rash

View on PRNewswire SEATTLE, Jan. 4, 2024 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a leading targeted oncology supportive...

Jun 6, 2023

OnQuality Announces FDA Clearance of IND Application for OQL051

View on PRNewswire SEATTLE, June 6, 2023 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive therapy...

Apr 28, 2023

OnQuality Announces FDA Clearance of IND Application for OQL036

View on PRNewswire SEATTLE, April 28, 2023 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive...

Apr 18, 2023

OnQuality Pharmaceuticals Presented Preclinical Data at the AACR Annual meeting

View on PRNewswire SEATTLE, April 18, 2023 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive...

Mar 15, 2023

OnQuality Pharmaceuticals Announces Presentations of OQL025 and OQL06x, at the AACR Annual Meeting

View on PRNewswire SEATTLE, March 15, 2023 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive...

Jan 5, 2023

OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India

View on PR Newswire SEATTLE, Jan. 5, 2023 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted oncology supportive therapy...